These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 21540481

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 23. Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients.
    Pfützner A, Hartmann K, Winter F, Fuchs GS, Kappelgaard AM, Rohrer TR.
    Clin Ther; 2010 Oct; 32(11):1918-34. PubMed ID: 21095487
    [Abstract] [Full Text] [Related]

  • 24. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE, Carrel AL, Whitman BY, Allen DB.
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB, Carrel AL.
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [Abstract] [Full Text] [Related]

  • 26. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
    Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 28. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone therapy for short stature: is the benefit worth the burden?
    Allen DB.
    Pediatrics; 2006 Jul; 118(1):343-8. PubMed ID: 16818584
    [No Abstract] [Full Text] [Related]

  • 30. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F, Karagiannis G, Wilton P.
    Horm Res; 2007 Jul; 68 Suppl 5():41-7. PubMed ID: 18174706
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone therapy.
    Bajpai A, Menon PS.
    Indian J Pediatr; 2005 Feb; 72(2):139-44. PubMed ID: 15758537
    [Abstract] [Full Text] [Related]

  • 32. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 33. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS, Mikkelsen S, Knudsen TK, Kappelgaard AM.
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [Abstract] [Full Text] [Related]

  • 34. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
    Ranke MB, Lindberg A.
    Horm Res Paediatr; 2011 Dec; 75(6):423-32. PubMed ID: 21358173
    [Abstract] [Full Text] [Related]

  • 35. [Growth hormone: who can benefit from it?].
    Schwarz HP.
    Ther Umsch; 1995 Oct; 52(10):678-81. PubMed ID: 7482379
    [Abstract] [Full Text] [Related]

  • 36. The multiple indications for growth hormone treatment of pediatric patients.
    Farber RS, Kerrigan JR.
    Pediatr Ann; 2006 Dec; 35(12):926-32. PubMed ID: 17236440
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone: the expansion of available products and indications.
    Franklin SL, Geffner ME.
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):587-611. PubMed ID: 19717006
    [Abstract] [Full Text] [Related]

  • 38. Growth hormone therapy in children and adults.
    Krysiak R, Gdula-Dymek A, Bednarska-Czerwińska A, Okopień B.
    Pharmacol Rep; 2007 Sep; 59(5):500-16. PubMed ID: 18048950
    [Abstract] [Full Text] [Related]

  • 39. The role of insulin-like growth factor I monitoring in growth hormone-treated children.
    Park P, Cohen P.
    Horm Res; 2004 Sep; 62 Suppl 1():59-65. PubMed ID: 15761234
    [Abstract] [Full Text] [Related]

  • 40. Therapy of growth disorders.
    Ali O, Wyatt D.
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.